rs879254335

Variant summary

Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4

The NM_000245.4(MET):​c.2864T>A​(p.Leu955Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)

Consequence

MET
NM_000245.4 missense

Scores

6
13

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.81
Variant links:
Genes affected
MET (HGNC:7029): (MET proto-oncogene, receptor tyrosine kinase) This gene encodes a member of the receptor tyrosine kinase family of proteins and the product of the proto-oncogene MET. The encoded preproprotein is proteolytically processed to generate alpha and beta subunits that are linked via disulfide bonds to form the mature receptor. Further processing of the beta subunit results in the formation of the M10 peptide, which has been shown to reduce lung fibrosis. Binding of its ligand, hepatocyte growth factor, induces dimerization and activation of the receptor, which plays a role in cellular survival, embryogenesis, and cellular migration and invasion. Mutations in this gene are associated with papillary renal cell carcinoma, hepatocellular carcinoma, and various head and neck cancers. Amplification and overexpression of this gene are also associated with multiple human cancers. [provided by RefSeq, May 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.39502907).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
METNM_000245.4 linkc.2864T>A p.Leu955Gln missense_variant Exon 13 of 21 ENST00000397752.8 NP_000236.2 P08581-1A0A024R759
METNM_001127500.3 linkc.2918T>A p.Leu973Gln missense_variant Exon 13 of 21 NP_001120972.1 P08581-2A0A024R728
METNM_001324402.2 linkc.1574T>A p.Leu525Gln missense_variant Exon 12 of 20 NP_001311331.1 B4DLF5
METXM_011516223.2 linkc.2921T>A p.Leu974Gln missense_variant Exon 14 of 22 XP_011514525.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
METENST00000397752.8 linkc.2864T>A p.Leu955Gln missense_variant Exon 13 of 21 1 NM_000245.4 ENSP00000380860.3 P08581-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
32
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Renal cell carcinoma Uncertain:1
Mar 27, 2016
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This sequence change replaces leucine with glutamine at codon 973 of the MET protein (p.Leu973Gln). The leucine residue is weakly conserved and there is a moderate physicochemical difference between leucine and glutamine. In summary, this variant is a novel missense change with uncertain impact on protein function and splicing. It has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). Algorithms developed to predict the effect of sequence changes on mRNA splicing suggest that this variant may alter mRNA splicing, but this prediction has not been confirmed by published transcriptional studies. This variant is not present in population databases (ExAC no frequency) and has not been reported in the literature in individuals with a MET-related disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.069
BayesDel_addAF
Uncertain
0.12
D
BayesDel_noAF
Uncertain
-0.070
CADD
Benign
21
DANN
Uncertain
0.98
DEOGEN2
Benign
0.35
T;.;.
Eigen
Benign
0.067
Eigen_PC
Benign
0.16
FATHMM_MKL
Uncertain
0.80
D
LIST_S2
Uncertain
0.88
D;D;D
M_CAP
Benign
0.050
D
MetaRNN
Benign
0.40
T;T;T
MetaSVM
Benign
-0.64
T
MutationAssessor
Benign
0.69
N;.;.
PrimateAI
Benign
0.38
T
PROVEAN
Benign
0.17
N;N;D
REVEL
Uncertain
0.39
Sift
Benign
0.097
T;T;D
Sift4G
Benign
0.38
T;T;D
Polyphen
0.21
B;P;.
Vest4
0.43
MutPred
0.59
Gain of loop (P = 0.0166);.;.;
MVP
0.86
MPC
0.65
ClinPred
0.80
D
GERP RS
4.6
Varity_R
0.27
gMVP
0.50

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs879254335; hg19: chr7-116411685; API